Evaluation of Xylitol Wipes as an Oral Hygiene Protocol for Haemophilic Children
NCT05899075 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2023-06-12
Summary
The purpose of this study is to evaluate xylitol wipes as an oral hygiene protocol for haemophilic children
Conditions
- Haemophilia
Interventions
- OTHER
-
xylitol wipes
group A will receive xylitol wipes and group B will receive placebo wipes
- OTHER
-
placebo wipes
group A will receive xylitol wipes and group B will receive placebo wipes
Sponsors & Collaborators
-
Al-Azhar University
lead OTHER
Principal Investigators
-
Hamdy Badreldin · AlAzhar U
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-20
- Primary Completion
- 2023-10-20
- Completion
- 2023-10-25
Countries
- Egypt
Study Locations
More Related Trials
-
Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A
NCT01790828 ·Status: COMPLETED
-
A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients
NCT02035605 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of XP12B in Women With Menorrhagia
NCT00401193 ·Status: COMPLETED ·Phase: PHASE3
-
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast
NCT05279924 ·Status: COMPLETED ·Phase: NA
-
Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia
NCT03914209 ·Status: UNKNOWN
-
Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A.
NCT04060836 ·Status: UNKNOWN ·Phase: PHASE1
-
Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews
NCT03054389 ·Status: COMPLETED
-
First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients
NCT01191372 ·Status: TERMINATED ·Phase: PHASE1
-
Study Evaluating The Safety Of Xyntha In Usual Care Settings
NCT00765726 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate Efficacy and Safety of Recombinant Factor VIII (rFVIII)Treatment of Severe or Moderately Severe Hemophilia A
NCT02930317 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip
NCT04592692 ·Status: UNKNOWN ·Phase: PHASE2
-
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
NCT06831734 ·Status: ENROLLING_BY_INVITATION
-
Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A
NCT02461992 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
NCT05987449 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Emicizumab Treatment in Patients With Hemophilia A
NCT07190118 ·Status: NOT_YET_RECRUITING
-
Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age
NCT00759655 ·Status: TERMINATED ·Phase: PHASE3
-
Data Registry in Chinese Hemophilia A and B Patients
NCT07101224 ·Status: COMPLETED
-
KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia
NCT05421429 ·Status: COMPLETED ·Phase: PHASE2
-
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A
NCT00717626 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia
NCT04878731 ·Status: COMPLETED ·Phase: PHASE1
-
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
NCT02971930 ·Status: COMPLETED
-
Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
NCT02324517 ·Status: UNKNOWN
-
ATHN 7: Hemophilia Natural History Study
NCT03619863 ·Status: COMPLETED
-
A Progressive Resistance Training Program in Patients With Haemophilia
NCT02781233 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
NCT02697370 ·Status: COMPLETED ·Phase: PHASE4